Oxbow Advisors LLC Buys 511 Shares of Cigna Group $CI

Oxbow Advisors LLC boosted its position in shares of Cigna Group (NYSE:CI) by 2.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,153 shares of the health services provider’s stock after acquiring an additional 511 shares during the period. Oxbow Advisors LLC’s holdings in Cigna Group were worth $6,662,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Flaharty Asset Management LLC acquired a new position in shares of Cigna Group in the 1st quarter valued at $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group in the 1st quarter valued at approximately $29,000. Activest Wealth Management raised its holdings in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after buying an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC boosted its stake in Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after buying an additional 43 shares in the last quarter. Finally, Saudi Central Bank acquired a new position in Cigna Group during the first quarter worth $36,000. 86.99% of the stock is currently owned by institutional investors.

Insider Activity at Cigna Group

In related news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by insiders.

Cigna Group Stock Down 1.2%

Shares of Cigna Group stock opened at $290.97 on Friday. The business has a fifty day simple moving average of $296.78 and a 200 day simple moving average of $308.51. The stock has a market cap of $77.67 billion, a PE ratio of 15.88, a price-to-earnings-growth ratio of 0.86 and a beta of 0.45. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.72.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the business posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Thursday, September 4th. Cigna Group’s payout ratio is 32.97%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Guggenheim reissued a “buy” rating and set a $350.00 price target (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Barclays lifted their price target on Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Cantor Fitzgerald restated an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Finally, Truist Financial set a $375.00 price target on shares of Cigna Group in a report on Tuesday, September 2nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $369.89.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.